Reaction

Pancreatic Pseudocyst reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 768 reports · 10 co-occurring drugs

As of the last recalculation, Pancreatic Pseudocyst appears in 768 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 38.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pegaspargase1738.538.5
Ampicillin1136.536.6
Ampicillin Sodium1136.536.6
Carboxymethylcellulose Sodium1132.232.2
Mercaptopurine1930.430.5
Minocycline818.818.8
Pancrelipase2417.417.4
Vincristine Sulfate1716.116.1
Liraglutide2815.915.9
Exenatide2513.313.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.